Echinococcus multilocularis Calreticulin Inhibits Lectin Pathway of Complement Activation by Directly Binding to Mannose-Binding Lectin
Pathogens · 2025
DOI: 10.3390/pathogens14040354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Yuxiao Shao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogenic Biology, School of Basic Medical Sciences and Forensic Medicine, Baotou Medical College, Baotou 014040, China. Hauptthemen laut MEDLINE: Calreticulin, Echinococcus multilocularis, Mannose-Binding Lectin, Complement Pathway, Mannose-Binding Lectin. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Inner Mongolia Youth Science and Technology Talent Support Program of Higher Education Institutions, Inner Mongolia Natural Science Foundation.
Abstract (Originalsprache)
Alveolar Echinococcosis (AE) is a serious zoonotic disease caused by infection of Echinococcus multilocularis larvae. To survive within the host, E. multilocularis has developed a complex immune evasion mechanism including the inhibition of complement activation. This study focused on a calreticulin secreted by E. multilocularis (EmCRT) and its role in binding ability to human MBL and inhibiting MBL-mannose-mediated lectin pathway of complement activation. Results demonstrated the binding of recombinant EmCRT protein to both external and natural MBL in serum and the subsequent inhibition of MBL-mannose-initiated lectin pathway reflected by the reduced formation of complement intermediate products C3b and C4b. Fragment mapping determined that the MBL binding site was located within the S-domain of EmCRT. Combining with its role in inhibiting C1q-initiated classical complement activation in our previous study, the inhibition of MBL-mannose-initiated lectin pathway identified in this study suggests EmCRT plays an important role in the immune evasion of E. multilocularis alveolar larvae against host complement attack as a survival strategy within human tissue. This study supports the approach of using EmCRT as a good candidate for vaccine and drug development against E. multilocularis infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogenic Biology, School of Basic Medical Sciences and Forensic Medicine, Baotou Medical College, Baotou 014040, China.
- Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Parasitology Research Laboratory, School of Life Sciences, Xiamen University, Xiamen 361102, China.
ORCID-Profile: Bin Zhan, Yanhai Wang
Förderung
- National Natural Science Foundation of China
- Inner Mongolia Youth Science and Technology Talent Support Program of Higher Education Institutions
- Inner Mongolia Natural Science Foundation
- Baotou Medical College Scientific Research Fund Project
Zitieren
APA
Shao, Y., Xia, M., Song, Y., Yan, Y., Dong, X., Zong, H., Zhan, B., Wang, Y., & Zhao, L. (2025). Echinococcus multilocularis Calreticulin Inhibits Lectin Pathway of Complement Activation by Directly Binding to Mannose-Binding Lectin. Pathogens. https://doi.org/10.3390/pathogens14040354
Vancouver
Shao Y, Xia M, Song Y, Yan Y, Dong X, Zong H, et al. Echinococcus multilocularis Calreticulin Inhibits Lectin Pathway of Complement Activation by Directly Binding to Mannose-Binding Lectin. Pathogens. 2025. doi:10.3390/pathogens14040354
BibTeX
@article{Shao2025,
author = {Shao, Yuxiao and Xia, Meng and Song, Yinghui and Yan, Yan and Dong, Xiaofang and Zong, Haoran and Zhan, Bin and Wang, Yanhai and Zhao, Limei},
title = {Echinococcus multilocularis Calreticulin Inhibits Lectin Pathway of Complement Activation by Directly Binding to Mannose-Binding Lectin},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14040354}
}
EUVIMED